Zobrazeno 1 - 10
of 122
pro vyhledávání: '"Frederick S Nolte"'
Autor:
David H. Persing, Fred C. Tenover, Yi-Wei Tang, Frederick S. Nolte, Randall T. Hayden, Alex van Belkum
The latest molecular diagnostic techniques presented in one comprehensive volume.
Autor:
Connor J. Dwyer, Colleen A. Cloud, Cindy Wang, Philip Heidt, Paramita Chakraborty, Tara F. Duke, Shannon McGue, Braxton Jeffcoat, Jaclyn Dunne, Logan Johnson, Seungho Choi, Georges J. Nahhas, Amy S. Gandy, Nikolina Babic, Frederick S. Nolte, Philip Howe, Besim Ogretmen, Vamsi K. Gangaraju, Stephen Tomlinson, Brian Madden, Tracy Bridges, Patrick A. Flume, John Wrangle, Mark P. Rubinstein, Prabhakar K. Baliga, Satish N. Nadig, Shikhar Mehrotra
Publikováno v:
iScience, Vol 24, Iss 6, Pp 102489- (2021)
Summary: The SARS-CoV-2 viral pandemic has induced a global health crisis, which requires more in-depth investigation into immunological responses to develop effective treatments and vaccines. To understand protective immunity against COVID-19, we sc
Externí odkaz:
https://doaj.org/article/81d3dd2c458348b2ad48c0ed81cf4392
Autor:
Sarah Y. Park, Eliza J Chang, Nathan Ledeboer, Kevin Messacar, Martin S. Lindner, Shivkumar Venkatasubrahmanyam, Sivan Bercovici, Judith C. Wilber, Marla Lay Vaughn, Bradley A. Perkins, Frederick S. Nolte
Microbial cell-free DNA (mcfDNA) sequencing is an emerging infectious disease diagnostic tool which enables unbiased pathogen detection from plasma. The Karius Test®, a commercial mcfDNA sequencing assay developed by and available since 2017 from Ka
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d80e7e1d11f3eafb9887ebc4d41b118
https://doi.org/10.1101/2023.01.03.22283605
https://doi.org/10.1101/2023.01.03.22283605
Publikováno v:
Open Forum Infectious Diseases. 9
Background Plasma microbial cell-free (mcfDNA) testing has emerged as a promising tool for unbiased detection of pathogens in patients with suspected infections. A systematic evaluation of the patient populations in which this test is used may provid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::03554342fb20d05c06f0a5bfe0506cc6
https://doi.org/10.1093/ofid/ofac492.405
https://doi.org/10.1093/ofid/ofac492.405
Autor:
Christopher D. Doern, Melissa B. Miller, Kevin Alby, Michael A. Bachman, Stephen M. Brecher, Aida Casiano-Colon, Marc Roger Couturier, J. Kristie Johnson, James E. Kirby, Erin McElvania, Duane W. Newton, Frederick S. Nolte, Preeti Pancholi, Peggy McNult, Vaishali Dharmarha, Sherry Dunbar
Publikováno v:
J Clin Microbiol
Clinical Microbiology Open (CMO), a meeting supported by the American Society for Microbiology’s Clinical and Public Health Microbiology Committee (CPHMC) and Corporate Council, provides a unique interactive platform for leaders from diagnostic mic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a99c363a3f9fd3ec9bc7d28b0b406a5c
https://doi.org/10.1128/jcm.00092-22
https://doi.org/10.1128/jcm.00092-22
Autor:
Isabella W. Martin, Marc Roger Couturier, Marie-Claire Rowlinson, David R. Peaper, Romney M. Humphries, Frederick S. Nolte, Elitza S. Theel, Rosemary C. She, Daniel D. Rhoads, Patricia J. Simner, Kaede V. Sullivan, Christina Wojewoda
Publikováno v:
Journal of Clinical Microbiology
The U.S. Food & Drug Administration (FDA) regulates the marketing of manufacturers’ in vitro diagnostic tests (IVDs), including assays for the detection of SARS-CoV-2. The U.S. government’s Clinical Laboratory Improvement Amendments (CLIA) of 198
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ed627b57431bdde75051ff2ec3b48b2
https://doi.org/10.1128/jcm.01167-21
https://doi.org/10.1128/jcm.01167-21
Autor:
Frederick S. Nolte
Publikováno v:
Clinical Chemistry. 66:140-142
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22319ec10d53ab814689aacd2dec6afc
https://doi.org/10.1373/clinchem.2019.304634
https://doi.org/10.1373/clinchem.2019.304634
Publikováno v:
The Journal of Applied Laboratory Medicine. 3:580-586
Background Procalcitonin (PCT) is a well-established marker for bacterial infection. Recently the US Food and Drug Administration approved the expanded use of this biomarker to guide clinical decisions for antibiotic treatment in patients with lower
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df626961d0e1d9af189675bb3601270c
https://doi.org/10.1373/jalm.2018.027268
https://doi.org/10.1373/jalm.2018.027268
Autor:
Julie Woolworth Hirschhorn, April Kegl, Gang Xu, W. Bailey Glen, Frederick S. Nolte, Tanisha Dickerson, Jay Alden
Publikováno v:
Journal of Clinical Microbiology
We verified the analytical performance of the Abbott RealTime SARS-CoV-2 assay on the m2000 system and compared its clinical performance to the CDC 2019-nCoV real-time PCR diagnostic panel and the Thermo Fisher TaqPath RT-PCR COVID-19 kit. We also pe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6151cc13149e101ae7e93e4ec88cb8d8
http://europepmc.org/articles/PMC8091852
http://europepmc.org/articles/PMC8091852
Autor:
Bobbi S. Pritt, Rosemary C. She, Daniel D. Rhoads, David R. Peaper, Frederick S. Nolte, Neil W. Anderson, Christina Wojewoda
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 72(10)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6b0a375460d2522cda6242804d6d7a9
https://pubmed.ncbi.nlm.nih.gov/32785648
https://pubmed.ncbi.nlm.nih.gov/32785648